Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 266.21M | 277.01M | 420.59M | 423.30M | 284.63M |
| Total Receivables | 378.74M | 394.11M | 345.15M | 347.37M | 380.12M |
| Inventory | 93.71M | 97.51M | 103.76M | 104.43M | 108.61M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.17M | 10.58M | 13.69M | 13.77M | 21.88M |
| Total Current Assets | 748.82M | 779.21M | 883.19M | 888.87M | 795.24M |
|
|
|||||
| Total Current Assets | 748.82M | 779.21M | 883.19M | 888.87M | 795.24M |
| Net Property, Plant & Equipment | 310.93M | 323.55M | 309.21M | 311.19M | 306.07M |
| Long-term Investments | 19.52M | 20.31M | 19.61M | 19.73M | 20.09M |
| Goodwill | 19.52M | 20.31M | 19.61M | 19.73M | 20.09M |
| Total Other Intangibles | 140.49M | 146.19M | 131.21M | 132.05M | 100.94M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 97.80M | 101.77M | 71.09M | 71.55M | 85.50M |
| Total Assets | 1.58B | 1.64B | 1.61B | 1.62B | 1.53B |
|
|
|||||
| Total Accounts Payable | 37.78M | 39.31M | 48.98M | 49.29M | 44.74M |
| Total Accrued Expenses | 141.22M | 146.95M | 123.16M | 123.95M | 147.44M |
| Short-term Debt | 143.91M | 149.75M | 136.75M | 137.63M | 107.52M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.35M | 9.73M | 11.63M | 11.71M | 46.90M |
| Total Finance Division Other Current Liabilities | 41.34M | 43.02M | 100.15M | 100.80M | 32.18M |
| Total Other Current Liabilities | 41.34M | 43.02M | 100.15M | 100.80M | 32.18M |
| Total Current Liabilities | 373.60M | 388.76M | 420.68M | 423.38M | 378.78M |
|
|
|||||
| Total Current Liabilities | 373.60M | 388.76M | 420.68M | 423.38M | 378.78M |
| Long-Term Debt | 1.13M | 1.18M | 1.17M | 1.18M | 29.03M |
| Short-term Debt | 143.91M | 149.75M | 136.75M | 137.63M | 107.52M |
| Capital Leases | 11.29M | 11.75M | 13.08M | 13.16M | 18.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 222.52M | 231.54M | 226.21M | 227.66M | 86.14M |
| Total Liabilities | 608.54M | 633.23M | 661.14M | 665.39M | 512.06M |
|
|
|||||
| Common Stock & APIC | 434.82M | 452.46M | 436.75M | 439.55M | 447.59M |
| Retained Earnings | 476.91M | 496.26M | 480.36M | 483.44M | 541.16M |
| Treasury Stock & Other | 56.62M | 58.92M | 33.61M | 33.82M | 29.84M |
| Total Common Equity | 968.35M | 1.01B | 950.71M | 956.82M | 1.02B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 968.35M | 1.01B | 950.71M | 956.82M | 1.02B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 968.35M | 1.01B | 950.71M | 956.82M | 1.02B |
|
|
|||||